Evidence map›Paper›PMID 21756937›Full record

ArticleJournal of neuroscience methods2011

A novel method for producing mono-biotinylated, biologically active neurotrophic factors: an essential reagent for single molecule study of axonal transport.

Kijung Sung, Michael T Maloney, Jingkun Yang, Chengbiao Wu

Abstract read
In one paragraph

Article in Journal of neuroscience methods, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.5field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Swedish Nerve Growth Factor Mutation (NGFThe Journal of neuroscience : the official journal of the Society for Neuroscience · 2018
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Site-specific biotinylation of purified proteins using BirA.Methods in molecular biology (Clifton, N.J.) · 2015
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Kijung SungDepartment of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA, USA.
Michael T Maloney
Jingkun Yang
Chengbiao Wu
Stanford University · USMassachusetts Institute of Technology · USUniversity of California, San Diego · US

Funding

Center for Protein Folding Machinery (RMI)PN2EY016525 · NEI · BAYLOR COLLEGE OF MEDICINE · PI CHIU, WAH · 2005 to 2015
$33.6M
NERVE GROWTH FACTOR--TROPHIC EFFECTS ON CNS NEURONSR01NS024054 · NINDS · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI MOBLEY, WILLIAM C · 1986 to 2008
$1.6M
Disrupted Transport of NGF-TrKA Signaling in Mouse Models of Down SyndromeR01NS055371 · NINDS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI MOBLEY, WILLIAM C · 2007 to 2010
$1.6M
NEI NIH HHS 2PN2EY16525NEI NIH HHS PN2 EY016525NINDS NIH HHS NS055371NINDS NIH HHS NS24054NINDS NIH HHS R01 NS024054NINDS NIH HHS R01 NS055371
6 · The paper itself

Abstract

In this report, we describe a novel method for producing mature and biologically active mono-biotinylated nerve growth factors (mBtNGF) that can be used for single molecule studies of real-time movement of neurotrophins within axons of neurons. We inserted an AviTag sequence into the C-terminal of the full length mouse preproNGF cDNA and cloned the fusion construct into a pcDNA3.1 mammalian expression vector. We also subcloned the Escherichia coli biotin ligase, BirA, into a pcDNA3.1 vector. These two plasmids were then transiently co-expressed in HEK293FT cells. As a result, the AviTag located in the C-terminal of preproNGF was selectively ligated to a single biotin by BirA. The prepro sequence of NGF was subsequently cleaved within the cell. Mature mono-biotinylated NGF (mBtNGF) was secreted into cell culture media and was purified using Ni resin. We carried out activity assays and our results showed that mBtNGF retained biological activities that were comparable to normal NGF purified from mouse sub maxillary glands. We further verified the biotinylation efficiency of mBtNGF and the level of non-biotinylated NGF was virtually undetectable in the final preparation. Finally, by conjugating to quantum-dot streptavidin, mBtNGF was successfully used for single molecule study of axonal NGF trafficking in neurons.

Indexed as

AnimalsAxonsBiological Transport, ActiveBiotinylationCarbon-Nitrogen LigasesCells, CulturedCloning, MolecularEmbryo, MammalianEscherichia coli ProteinsGanglia, SpinalGreen Fluorescent ProteinsHumansMiceMicroscopy, ConfocalMolecular Probe TechniquesNerve Growth FactorbirA protein, E coliCarbon-Nitrogen LigasesEscherichia coli ProteinsGreen Fluorescent ProteinsNerve Growth FactorRepressor Proteins

Identifiers

PMID21756937
PMCPMC3158612
OpenAlexW2088310077

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.